South Korea Eutilex’s CEO, Byoung S. Kwon, outlines the company’s approach to cancer research, including its antibodies and CAR-T-centred pipeline and focus on unmet needs. He also explains recent partnerships in China. … these different therapeutic platforms are based upon how we can handle these T-cells to attack cancer, and then…
See our Cookie Privacy Policy Here